Published in Virology on January 05, 2013
CDK1 substitutes for mTOR kinase to activate mitotic cap-dependent protein translation. Proc Natl Acad Sci U S A (2015) 1.61
Therapeutic cancer vaccines. J Clin Invest (2015) 1.23
Characterization of a novel polyomavirus isolated from a fibroma on the trunk of an African elephant (Loxodonta africana). PLoS One (2013) 0.95
T-cell responses to oncogenic merkel cell polyomavirus proteins distinguish patients with merkel cell carcinoma from healthy donors. Clin Cancer Res (2014) 0.94
Human polyomavirus reactivation: disease pathogenesis and treatment approaches. Clin Dev Immunol (2013) 0.89
Tumorigenic activity of merkel cell polyomavirus T antigens expressed in the stratified epithelium of mice. Cancer Res (2015) 0.89
Divergent MicroRNA targetomes of closely related circulating strains of a polyomavirus. J Virol (2013) 0.87
The role of Merkel cell polyomavirus and other human polyomaviruses in emerging hallmarks of cancer. Viruses (2015) 0.85
Aberrant Promoter Hypermethylation of RASSF Family Members in Merkel Cell Carcinoma. Cancers (Basel) (2013) 0.83
Removal of a small C-terminal region of JCV and SV40 large T antigens has differential effects on transformation. Virology (2014) 0.81
Post-transplantation malignancies: here today, gone tomorrow? Nat Rev Clin Oncol (2015) 0.81
Seroprevalence of Merkel cell polyomavirus in the general rural population of Anyang, China. PLoS One (2014) 0.81
Reactivation of human polyomaviruses in immunocompromised states. J Neurovirol (2014) 0.80
Multiple primary cancers associated with Merkel cell carcinoma in Queensland, Australia, 1982-2011. J Invest Dermatol (2014) 0.79
Merkel cell polyomavirus T antigens promote cell proliferation and inflammatory cytokine gene expression. J Gen Virol (2015) 0.78
Characterization of self-assembled virus-like particles of Merkel cell polyomavirus. PLoS One (2015) 0.78
Interaction of human tumor viruses with host cell surface receptors and cell entry. Viruses (2015) 0.78
Identification of episomal human papillomavirus and other DNA viruses in cytological anal samples of HIV-uninfected men who have sex with men. PLoS One (2013) 0.78
Merkel cell carcinoma occurring in a black woman: a case report. J Med Case Rep (2017) 0.75
Immunotherapy against cancer-related viruses. Cell Res (2016) 0.75
Merkel cell polyomavirus infection and Merkel cell carcinoma. Curr Opin Virol (2016) 0.75
Merkel cell polyomavirus and cutaneous Merkel cell carcinoma. Future Sci OA (2016) 0.75
Incidental Merkel cell carcinoma in a cutaneous horn: a case report. Dermatol Pract Concept (2015) 0.75
Small Circular DNAs in Human Pathology. Malays J Med Sci (2014) 0.75
Identification of Merkel Cell Polyomavirus from a Patient with Acute Myeloid Leukemia. Genome Announc (2017) 0.75
Suppression of immunodominant antitumor and antiviral CD8+ T cell responses by indoleamine 2,3-dioxygenase. PLoS One (2014) 0.75
MGMT promoter methylation status in Merkel cell carcinoma: in vitro versus invivo. J Cancer Res Clin Oncol (2017) 0.75
Expression of Merkelcell polyomavirus (MCPyV) large T-antigen in Merkel cell carcinoma lymph node metastases predicts poor outcome. PLoS One (2017) 0.75
Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science (1994) 39.60
T antigen is bound to a host protein in SV40-transformed cells. Nature (1979) 17.78
Clonal integration of a polyomavirus in human Merkel cell carcinoma. Science (2008) 16.60
Characterization of a 54K dalton cellular SV40 tumor antigen present in SV40-transformed cells and uninfected embryonal carcinoma cells. Cell (1979) 14.05
SV40 large tumor antigen forms a specific complex with the product of the retinoblastoma susceptibility gene. Cell (1988) 12.69
Insulin-dependent stimulation of protein synthesis by phosphorylation of a regulator of 5'-cap function. Nature (1994) 9.30
Simian virus 40 DNA replication in vitro. Proc Natl Acad Sci U S A (1984) 7.76
The vacuolating virus, S.V. 40. Proc Soc Exp Biol Med (1960) 7.32
Association of phosphatidylinositol kinase activity with polyoma middle-T competent for transformation. Nature (1985) 7.10
An activity phosphorylating tyrosine in polyoma T antigen immunoprecipitates. Cell (1979) 7.02
Polyoma small and middle T antigens and SV40 small t antigen form stable complexes with protein phosphatase 2A. Cell (1990) 6.12
Construction and characterization of an SV40 mutant defective in nuclear transport of T antigen. Cell (1984) 5.81
Transformation induced by simian virus 40 in human renal cell cultures. I. Morphology and growth characteristics. Proc Natl Acad Sci U S A (1962) 5.15
Anatomy of a DNA replication fork revealed by reconstitution of SV40 DNA replication in vitro. Nature (1994) 4.96
Enumeration of the simian virus 40 early region elements necessary for human cell transformation. Mol Cell Biol (2002) 4.77
T antigen mutations are a human tumor-specific signature for Merkel cell polyomavirus. Proc Natl Acad Sci U S A (2008) 4.74
Merkel cell carcinoma and HIV infection. Lancet (2002) 4.72
Clinical characteristics of Merkel cell carcinoma at diagnosis in 195 patients: the AEIOU features. J Am Acad Dermatol (2008) 4.69
Seroepidemiology of human polyomaviruses. PLoS Pathog (2009) 4.62
Merkel cell polyomavirus and two previously unknown polyomaviruses are chronically shed from human skin. Cell Host Microbe (2010) 3.78
Merkel cell carcinoma: changing incidence trends. J Surg Oncol (2005) 3.78
SV40 large T antigen targets multiple cellular pathways to elicit cellular transformation. Oncogene (2005) 3.77
Trabecular carcinoma of the skin. Arch Dermatol (1972) 3.66
Frequent detection of Merkel cell polyomavirus in human Merkel cell carcinomas and identification of a unique deletion in the VP1 gene. Cancer Res (2008) 3.32
Common and unique features of T antigens encoded by the polyomavirus group. J Virol (1992) 3.31
MC polyomavirus is frequently present in Merkel cell carcinoma of European patients. J Invest Dermatol (2008) 3.29
Identification of the oncogenic substance in rhesus monkey kidney cell culture as simian virus 40. Virology (1962) 3.22
Discovery of a new human polyomavirus associated with trichodysplasia spinulosa in an immunocompromized patient. PLoS Pathog (2010) 3.15
A filterable agent, recovered from Ak leukemic extracts, causing salivary gland carcinomas in C3H mice. Proc Soc Exp Biol Med (1953) 3.01
Merkel cell carcinoma and melanoma: etiological similarities and differences. Cancer Epidemiol Biomarkers Prev (1999) 2.97
Merkel cell polyomavirus-infected Merkel cell carcinoma cells require expression of viral T antigens. J Virol (2010) 2.88
Merkel cell polyomavirus is more frequently present in North American than Australian Merkel cell carcinoma tumors. J Invest Dermatol (2008) 2.80
Human Merkel cell polyomavirus infection I. MCV T antigen expression in Merkel cell carcinoma, lymphoid tissues and lymphoid tumors. Int J Cancer (2009) 2.78
Human Merkel cell polyomavirus infection II. MCV is a common human infection that can be detected by conformational capsid epitope immunoassays. Int J Cancer (2009) 2.77
Merkel cell carcinoma: more deaths but still no pathway to blame. J Invest Dermatol (2007) 2.72
Induction of malignancy in vitro in newborn hamster kidney tissue infected with simian vacuolating virus (SV40). Proc Soc Exp Biol Med (1962) 2.68
Why do viruses cause cancer? Highlights of the first century of human tumour virology. Nat Rev Cancer (2010) 2.68
Human transcriptome subtraction by using short sequence tags to search for tumor viruses in conjunctival carcinoma. J Virol (2007) 2.68
Merkel cell carcinoma demographics, morphology, and survival based on 3870 cases: a population based study. J Cutan Pathol (2009) 2.63
Epidemiology of primary Merkel cell carcinoma in the United States. J Am Acad Dermatol (2003) 2.56
Merkel's cell carcinoma in organ recipients: report of 41 cases. Transplantation (1999) 2.47
Human Merkel cell polyomavirus small T antigen is an oncoprotein targeting the 4E-BP1 translation regulator. J Clin Invest (2011) 2.37
Reactivation and mutation of newly discovered WU, KI, and Merkel cell carcinoma polyomaviruses in immunosuppressed individuals. J Infect Dis (2009) 2.28
Association of Merkel cell polyomavirus-specific antibodies with Merkel cell carcinoma. J Natl Cancer Inst (2009) 2.22
Is there a role for SV40 in human cancer? J Clin Oncol (2006) 2.15
Identification of MW polyomavirus, a novel polyomavirus in human stool. J Virol (2012) 2.10
Quantitation of human seroresponsiveness to Merkel cell polyomavirus. PLoS Pathog (2009) 2.08
Taxonomical developments in the family Polyomaviridae. Arch Virol (2011) 2.03
A novel human polyomavirus closely related to the african green monkey-derived lymphotropic polyomavirus. J Virol (2011) 2.03
Friedrich Sigmund Merkel and his "Merkel cell", morphology, development, and physiology: review and new results. Anat Rec A Discov Mol Cell Evol Biol (2003) 1.96
Tumors induced in hamsters by injection of rhesus monkey kidney cell extracts. Proc Soc Exp Biol Med (1961) 1.79
Merkel cell polyomavirus expression in merkel cell carcinomas and its absence in combined tumors and pulmonary neuroendocrine carcinomas. Am J Surg Pathol (2009) 1.79
New insights into merkel cell carcinoma. Adv Anat Pathol (2010) 1.77
UV-B-type mutations and chromosomal imbalances indicate common pathways for the development of Merkel and skin squamous cell carcinomas. Int J Cancer (2002) 1.66
Merkel cell carcinoma of the skin: pathological and molecular evidence for a causative role of MCV in oncogenesis. J Pathol (2009) 1.65
Quantitative detection of Merkel cell virus in human tissues and possible mode of transmission. Int J Cancer (2010) 1.53
Merkel cell polyomavirus in cutaneous squamous cell carcinoma of immunocompetent individuals. J Invest Dermatol (2009) 1.53
The minimum replication origin of merkel cell polyomavirus has a unique large T-antigen loading architecture and requires small T-antigen expression for optimal replication. J Virol (2009) 1.52
An intact retinoblastoma protein-binding site in Merkel cell polyomavirus large T antigen is required for promoting growth of Merkel cell carcinoma cells. Int J Cancer (2011) 1.49
Merkel cell polyomavirus sequences are frequently detected in nonmelanoma skin cancer of immunosuppressed patients. Int J Cancer (2009) 1.49
Merkel cell polyomavirus in respiratory tract secretions. Emerg Infect Dis (2009) 1.49
Complete genome sequence of a tenth human polyomavirus. J Virol (2012) 1.48
Merkel cell carcinoma: a virus-induced human cancer. Annu Rev Pathol (2011) 1.46
Detection of Merkel cell polyomavirus in Merkel cell carcinoma and Kaposi's sarcoma. J Med Virol (2009) 1.46
Merkel cell polyomavirus DNA in persons without merkel cell carcinoma. Emerg Infect Dis (2009) 1.45
Merkel cell polyomavirus infection, large T antigen, retinoblastoma protein and outcome in Merkel cell carcinoma. Clin Cancer Res (2011) 1.44
Merkel cell carcinoma subgroups by Merkel cell polyomavirus DNA relative abundance and oncogene expression. Int J Cancer (2010) 1.42
Prevalence of Merkel cell polyomavirus in Merkel cell carcinoma. Mod Pathol (2009) 1.41
Generation of Merkel cell polyomavirus (MCV)-like particles and their application to detection of MCV antibodies. J Clin Microbiol (2010) 1.40
Distinct merkel cell polyomavirus molecular features in tumour and non tumour specimens from patients with merkel cell carcinoma. PLoS Pathog (2010) 1.40
Independent expression of the transforming amino-terminal domain of SV40 large I antigen from an alternatively spliced third SV40 early mRNA. EMBO J (1993) 1.39
Merkel cell polyomavirus DNA in respiratory specimens from children and adults. Emerg Infect Dis (2009) 1.39
KI, WU and Merkel cell polyomaviruses: a new era for human polyomavirus research. Semin Cancer Biol (2009) 1.37
Human polyomavirus related to African green monkey lymphotropic polyomavirus. Emerg Infect Dis (2011) 1.36
Age-specific seroprevalence of Merkel cell polyomavirus, BK virus, and JC virus. Clin Vaccine Immunol (2011) 1.35
Serological evidence of Merkel cell polyomavirus primary infections in childhood. J Clin Virol (2010) 1.34
Neuroendocrine (Merkel) cells of the skin: hyperplasias, dysplasias, and neoplasms. Lab Invest (1985) 1.33
Merkel cell polyomavirus encodes a microRNA with the ability to autoregulate viral gene expression. Virology (2008) 1.33
Merkel cell polyomavirus in cutaneous swabs. Emerg Infect Dis (2010) 1.25
Immunosuppression and Merkel cell cancer. Transplant Proc (2002) 1.25
SV40 DNA replication: from the A gene to a nanomachine. Virology (2008) 1.25
Merkel cell polyomavirus DNA detection in lesional and nonlesional skin from patients with Merkel cell carcinoma or other skin diseases. Br J Dermatol (2009) 1.23
Cellular and viral factors regulating Merkel cell polyomavirus replication. PLoS One (2011) 1.21
Viruses and sialic acids: rules of engagement. Curr Opin Struct Biol (2011) 1.21
Carcinogenicity of malaria and of some polyomaviruses. Lancet Oncol (2012) 1.19
Glycosaminoglycans and sialylated glycans sequentially facilitate Merkel cell polyomavirus infectious entry. PLoS Pathog (2011) 1.19
Genetic variability and integration of Merkel cell polyomavirus in Merkel cell carcinoma. Virology (2012) 1.16
The Polyomaviridae: Contributions of virus structure to our understanding of virus receptors and infectious entry. Virology (2009) 1.15
Prevalence of MCPyV in Merkel cell carcinoma and non-MCC tumors. J Cutan Pathol (2009) 1.15
Merkel cell carcinoma after chronic lymphocytic leukemia: case report and literature review. Am J Clin Oncol (2003) 1.15
Merkel cell polyomavirus DNA in tumor-free tonsillar tissues and upper respiratory tract samples: implications for respiratory transmission and latency. J Clin Virol (2009) 1.14
Human Merkel cells--aspects of cell biology, distribution and functions. Eur J Cell Biol (2005) 1.13
The crystal structure of the SV40 T-antigen origin binding domain in complex with DNA. PLoS Biol (2007) 1.12
Ganglioside GT1b is a putative host cell receptor for the Merkel cell polyomavirus. J Virol (2009) 1.10
Structure of the origin-binding domain of simian virus 40 large T antigen bound to DNA. EMBO J (2006) 1.07
Detection of Merkel cell polyomavirus DNA in Merkel cell carcinomas. Br J Dermatol (2009) 1.07
Nuclear localization of Merkel cell polyomavirus large T antigen in Merkel cell carcinoma. Virology (2010) 1.05
Inflammatory monocytes are a reservoir for Merkel cell polyomavirus. J Invest Dermatol (2009) 1.04
Mechanisms of cell entry by human papillomaviruses: an overview. Virol J (2010) 1.04
Immunological detection of viral large T antigen identifies a subset of Merkel cell carcinoma tumors with higher viral abundance and better clinical outcome. Int J Cancer (2010) 1.03
Fundamental differences in cell cycle deregulation in human papillomavirus-positive and human papillomavirus-negative head/neck and cervical cancers. Cancer Res (2007) 2.93
Dissection of human papillomavirus E6 and E7 function in transgenic mouse models of cervical carcinogenesis. Cancer Res (2003) 2.32
Establishment of human papillomavirus infection requires cell cycle progression. PLoS Pathog (2009) 1.94
The PDZ ligand domain of the human papillomavirus type 16 E6 protein is required for E6's induction of epithelial hyperplasia in vivo. J Virol (2003) 1.91
Enhanced radiation sensitivity in HPV-positive head and neck cancer. Cancer Res (2013) 1.87
Structural and functional consequences of glutamine tract variation in the androgen receptor. Hum Mol Genet (2004) 1.74
Production of infectious human papillomavirus independently of viral replication and epithelial cell differentiation. Proc Natl Acad Sci U S A (2005) 1.72
Identification of biomarkers that distinguish human papillomavirus (HPV)-positive versus HPV-negative head and neck cancers in a mouse model. Proc Natl Acad Sci U S A (2006) 1.57
The minor capsid protein L2 contributes to two steps in the human papillomavirus type 31 life cycle. J Virol (2005) 1.53
Estrogen contributes to the onset, persistence, and malignant progression of cervical cancer in a human papillomavirus-transgenic mouse model. Proc Natl Acad Sci U S A (2005) 1.50
Quantitative role of the human papillomavirus type 16 E5 gene during the productive stage of the viral life cycle. J Virol (2003) 1.49
Recapitulation of the effects of the human papillomavirus type 16 E7 oncogene on mouse epithelium by somatic Rb deletion and detection of pRb-independent effects of E7 in vivo. Mol Cell Biol (2003) 1.43
The human papillomavirus E6 oncogene dysregulates the cell cycle and contributes to cervical carcinogenesis through two independent activities. Cancer Res (2007) 1.39
Methylation patterns of papillomavirus DNA, its influence on E2 function, and implications in viral infection. J Virol (2003) 1.37
Requirement of epidermal growth factor receptor for hyperplasia induced by E5, a high-risk human papillomavirus oncogene. Cancer Res (2005) 1.34
Estrogen and ERalpha: culprits in cervical cancer? Trends Endocrinol Metab (2010) 1.33
Human papillomavirus type 16 E1circumflexE4 contributes to multiple facets of the papillomavirus life cycle. J Virol (2005) 1.32
The human papillomavirus type 16 E7 oncoprotein activates the Fanconi anemia (FA) pathway and causes accelerated chromosomal instability in FA cells. J Virol (2007) 1.29
Impaired antigen presentation and effectiveness of combined active/passive immunotherapy for epithelial tumors. J Natl Cancer Inst (2004) 1.28
Requirement of PDZ-containing proteins for cell cycle regulation and differentiation in the mouse lens epithelium. Mol Cell Biol (2003) 1.27
Deficiencies in the Fanconi anemia DNA damage response pathway increase sensitivity to HPV-associated head and neck cancer. Cancer Res (2010) 1.26
Requirement for estrogen receptor alpha in a mouse model for human papillomavirus-associated cervical cancer. Cancer Res (2008) 1.21
Critical roles for non-pRb targets of human papillomavirus type 16 E7 in cervical carcinogenesis. Cancer Res (2006) 1.21
Development and characterization of HPV-positive and HPV-negative head and neck squamous cell carcinoma tumorgrafts. Clin Cancer Res (2012) 1.20
Interactions with pocket proteins contribute to the role of human papillomavirus type 16 E7 in the papillomavirus life cycle. J Virol (2005) 1.16
Two distinct activities contribute to human papillomavirus 16 E6's oncogenic potential. Cancer Res (2005) 1.15
DEK proto-oncogene expression interferes with the normal epithelial differentiation program. Am J Pathol (2008) 1.15
A mutant of human papillomavirus type 16 E6 deficient in binding alpha-helix partners displays reduced oncogenic potential in vivo. J Virol (2002) 1.15
Role of Rb-dependent and Rb-independent functions of papillomavirus E7 oncogene in head and neck cancer. Cancer Res (2007) 1.13
Human papillomavirus type 16 E1 E4-induced G2 arrest is associated with cytoplasmic retention of active Cdk1/cyclin B1 complexes. J Virol (2005) 1.10
Stable replication of papillomavirus genomes in Saccharomyces cerevisiae. J Virol (2002) 1.07
p53 Loss synergizes with estrogen and papillomaviral oncogenes to induce cervical and breast cancers. Cancer Res (2008) 1.06
Key Characteristics of Carcinogens as a Basis for Organizing Data on Mechanisms of Carcinogenesis. Environ Health Perspect (2015) 1.05
Examination of the pRb-dependent and pRb-independent functions of E7 in vivo. J Virol (2005) 1.05
Persistence of high-grade cervical dysplasia and cervical cancer requires the continuous expression of the human papillomavirus type 16 E7 oncogene. Cancer Res (2009) 1.04
Prevention and treatment of cervical cancer in mice using estrogen receptor antagonists. Proc Natl Acad Sci U S A (2009) 1.04
Effects of cellular differentiation, chromosomal integration and 5-aza-2'-deoxycytidine treatment on human papillomavirus-16 DNA methylation in cultured cell lines. Virology (2008) 1.04
A role for HPV16 E5 in cervical carcinogenesis. Cancer Res (2010) 1.03
Human papillomavirus E7 oncoprotein overrides the tumor suppressor activity of p21Cip1 in cervical carcinogenesis. Cancer Res (2009) 1.02
The fanconi anemia pathway limits human papillomavirus replication. J Virol (2012) 1.01
Epigenetics of human papillomaviruses. Virology (2013) 1.00
Human papillomavirus type 16 E6 and E7 oncoproteins act synergistically to cause head and neck cancer in mice. Virology (2010) 1.00
Phosphorylation of p53 at serine 37 is important for transcriptional activity and regulation in response to DNA damage. Oncogene (2004) 1.00
Requirement for stromal estrogen receptor alpha in cervical neoplasia. Horm Cancer (2012) 1.00
Human papillomavirus 16 E5 oncogene contributes to two stages of skin carcinogenesis. Cancer Res (2007) 0.98
Rapamycin inhibits anal carcinogenesis in two preclinical animal models. Cancer Prev Res (Phila) (2010) 0.96
A mouse model for human anal cancer. Cancer Prev Res (Phila) (2010) 0.96
Prevalence of human papillomavirus in oropharyngeal squamous cell carcinoma in the United States across time. Chem Res Toxicol (2014) 0.96
Human papillomavirus 16 E6 variants differ in their dysregulation of human keratinocyte differentiation and apoptosis. Virology (2008) 0.95
Inhibition of gamma secretase blocks HPV infection. Virology (2010) 0.94
Identification of cis-acting elements that mediate the replication and maintenance of human papillomavirus type 16 genomes in Saccharomyces cerevisiae. J Virol (2005) 0.94
Rare human papillomavirus 16 E6 variants reveal significant oncogenic potential. Mol Cancer (2011) 0.93
Inactivating all three rb family pocket proteins is insufficient to initiate cervical cancer. Cancer Res (2012) 0.93
Cervical cancers require the continuous expression of the human papillomavirus type 16 E7 oncoprotein even in the presence of the viral E6 oncoprotein. Cancer Res (2012) 0.92
E1 protein of bovine papillomavirus 1 is not required for the maintenance of viral plasmid DNA replication. Virology (2002) 0.92
Induction of promyelocytic leukemia (PML) oncogenic domains (PODs) by papillomavirus. Virology (2007) 0.91
Down-regulation of transforming growth factor-beta type II receptor (TGF-betaRII) protein and mRNA expression in cervical cancer. Mol Cancer (2008) 0.91
Inactivation of p53 rescues the maintenance of high risk HPV DNA genomes deficient in expression of E6. PLoS Pathog (2013) 0.90
E6-associated protein is required for human papillomavirus type 16 E6 to cause cervical cancer in mice. Cancer Res (2010) 0.90
High incidence of HPV-associated head and neck cancers in FA deficient mice is associated with E7's induction of DNA damage through its inactivation of pocket proteins. PLoS One (2013) 0.90
Pocket proteins suppress head and neck cancer. Cancer Res (2012) 0.89
Expression of a single, viral oncoprotein in skin epithelium is sufficient to recruit lymphocytes. PLoS One (2013) 0.89
E6 and E7 oncoproteins induce distinct patterns of chromosomal aneuploidy in skin tumors from transgenic mice. Cancer Res (2004) 0.89
Dominant role of HPV16 E7 in anal carcinogenesis. Virology (2011) 0.88
The E6 oncoprotein from HPV16 enhances the canonical Wnt/β-catenin pathway in skin epidermis in vivo. Mol Cancer Res (2011) 0.87
Use of an in vivo animal model for assessing the role of integrin α(6)β(4) and syndecan-1 in early steps in papillomavirus infection. Virology (2012) 0.87
IFN-κ, a novel type I IFN, is undetectable in HPV-positive human cervical keratinocytes. Lab Invest (2010) 0.84
Prevalence of Human Papillomavirus in Oropharyngeal Cancer: A Systematic Review. Cancer J (2015) 0.83
Requirement for Dlgh-1 in planar cell polarity and skeletogenesis during vertebrate development. PLoS One (2013) 0.83
Sonoporation delivery of monoclonal antibodies against human papillomavirus 16 E6 restores p53 expression in transformed cervical keratinocytes. PLoS One (2012) 0.83
The HPV16 oncogenes cause aberrant stem cell mobilization. Virology (2013) 0.81
Requirement of estrogen receptor alpha DNA-binding domain for HPV oncogene-induced cervical carcinogenesis in mice. Carcinogenesis (2013) 0.81
HUMAN PAPILLOMAVIRUS ASSOCIATION WITH HEAD AND NECK CANCERS: UNDERSTANDING VIRUS BIOLOGY AND USING IT IN THE DEVELOPMENT OF CANCER DIAGNOSTICS. Expert Opin Med Diagn (2008) 0.80
Gene expression profile regulated by the HPV16 E7 oncoprotein and estradiol in cervical tissue. Virology (2013) 0.80
Gene expression analysis of interferon kappa in laser capture microdissected cervical epithelium. Anal Biochem (2008) 0.80
TGFβ signaling regulates lipogenesis in human sebaceous glands cells. BMC Dermatol (2013) 0.79
Papillomavirus E6 oncoprotein up-regulates occludin and ZO-2 expression in ovariectomized mice epidermis. Exp Cell Res (2013) 0.78
Novel antivirals inhibit early steps in HPV infection. Antiviral Res (2011) 0.77
Identifying the Target Cells and Mechanisms of Merkel Cell Polyomavirus Infection. Cell Host Microbe (2016) 0.76
The interwoven story of the small DNA tumor viruses. Virology (2009) 0.75
Characterization of interactions between transcription factors and a regulatory region spanning nt -320 to -281 of the HIV-1 LTR in T-lymphoid and non-T-lymphoid cells. J Biomed Sci (2002) 0.75